Item 8.01. Other Events.
On February 27, 2023, Aptinyx Inc. issued a press release titled "Aptinyx
Reports Results from Phase 2 Study of NYX-458 in Cognitive Impairment Associated
with Parkinson's Disease and Dementia with Lewy Bodies and Provides Pipeline and
Corporate Update." A copy of the press release is attached hereto as Exhibit
99.1 and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit No. Description
99.1 Press release issued by Aptinyx Inc. on February 27, 2023, furnished
herewith
104 Cover Page Interactive Data File
2
© Edgar Online, source Glimpses